Variant report
Variant | nsv611149 |
---|---|
Chromosome Location | chr8:43124666-43791691 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2524)
- CpG islands (count:2934)
- Chromatin interactive region (count:13)
- LncRNA region (count:14)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr8:43786577-43787136 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr8:43785555-43785668 | K562 | blood: | n/a | n/a |
3 | ATF3 | chr8:43147119-43147233 | K562 | blood: | n/a | n/a |
4 | ATF3 | chr8:43136024-43136278 | K562 | blood: | n/a | n/a |
5 | ATF3 | chr8:43135995-43136320 | GM12878 | blood: | n/a | n/a |
6 | ATF3 | chr8:43136037-43136199 | HepG2 | liver: | n/a | n/a |
7 | ATF3 | chr8:43135865-43136266 | HepG2 | liver: | n/a | n/a |
8 | BACH1 | chr8:43572418-43572443 | K562 | blood: | n/a | n/a |
9 | BACH1 | chr8:43790059-43790248 | K562 | blood: | n/a | n/a |
10 | BACH1 | chr8:43654724-43654750 | K562 | blood: | n/a | n/a |
11 | BACH1 | chr8:43779446-43779599 | K562 | blood: | n/a | n/a |
12 | BACH1 | chr8:43717526-43717725 | K562 | blood: | n/a | n/a |
13 | BATF | chr8:43760193-43760718 | GM12878 | blood: | n/a | n/a |
14 | BATF | chr8:43789506-43789826 | GM12878 | blood: | n/a | n/a |
15 | BATF | chr8:43772038-43772467 | GM12878 | blood: | n/a | n/a |
16 | BATF | chr8:43790975-43791219 | GM12878 | blood: | n/a | n/a |
17 | BATF | chr8:43760917-43761158 | GM12878 | blood: | n/a | n/a |
18 | BATF | chr8:43790368-43790722 | GM12878 | blood: | n/a | n/a |
19 | BATF | chr8:43761295-43761752 | GM12878 | blood: | n/a | n/a |
20 | BATF | chr8:43789506-43789769 | GM12878 | blood: | n/a | n/a |
21 | BATF | chr8:43783535-43783800 | GM12878 | blood: | n/a | n/a |
22 | BATF | chr8:43790147-43790722 | GM12878 | blood: | n/a | n/a |
23 | BATF | chr8:43776273-43776586 | GM12878 | blood: | n/a | n/a |
24 | BATF | chr8:43771212-43771629 | GM12878 | blood: | n/a | n/a |
25 | BATF | chr8:43783610-43783797 | GM12878 | blood: | n/a | n/a |
26 | BATF | chr8:43771808-43772466 | GM12878 | blood: | n/a | n/a |
27 | BATF | chr8:43770392-43770728 | GM12878 | blood: | n/a | n/a |
28 | BATF | chr8:43785488-43786069 | GM12878 | blood: | n/a | n/a |
29 | BATF | chr8:43761208-43761764 | GM12878 | blood: | n/a | n/a |
30 | BATF | chr8:43764727-43764995 | GM12878 | blood: | n/a | n/a |
31 | BATF | chr8:43771245-43771622 | GM12878 | blood: | n/a | n/a |
32 | BATF | chr8:43759902-43760143 | GM12878 | blood: | n/a | n/a |
33 | BATF | chr8:43760280-43760716 | GM12878 | blood: | n/a | n/a |
34 | BATF | chr8:43781686-43781952 | GM12878 | blood: | n/a | n/a |
35 | BATF | chr8:43778905-43779151 | GM12878 | blood: | n/a | n/a |
36 | BATF | chr8:43785460-43785804 | GM12878 | blood: | n/a | n/a |
37 | BATF | chr8:43781687-43781911 | GM12878 | blood: | n/a | n/a |
38 | BATF | chr8:43782910-43783364 | GM12878 | blood: | n/a | n/a |
39 | BCL11A | chr8:43761170-43762049 | GM12878 | blood: | n/a | n/a |
40 | BCL11A | chr8:43778827-43779220 | GM12878 | blood: | n/a | n/a |
41 | BCL11A | chr8:43771282-43771511 | GM12878 | blood: | n/a | n/a |
42 | BCL11A | chr8:43790385-43790700 | GM12878 | blood: | n/a | n/a |
43 | BCL11A | chr8:43782626-43783058 | GM12878 | blood: | n/a | n/a |
44 | BCL11A | chr8:43760155-43760933 | GM12878 | blood: | n/a | n/a |
45 | BCL11A | chr8:43789364-43789781 | GM12878 | blood: | n/a | n/a |
46 | BCL11A | chr8:43772033-43772507 | GM12878 | blood: | n/a | n/a |
47 | BCL11A | chr8:43785837-43785995 | GM12878 | blood: | n/a | n/a |
48 | BCL11A | chr8:43783550-43783791 | GM12878 | blood: | n/a | n/a |
49 | BCL11A | chr8:43783542-43783935 | GM12878 | blood: | n/a | n/a |
50 | BCL11A | chr8:43785261-43786095 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:43404458-43404508 | MCF10A-Er-Src | breast: | n/a |
2 | chr8:43401874-43401924 | NHDF-neo | bronchial: | n/a |
3 | chr8:43131535-43131585 | U87 | brain: | n/a |
4 | chr8:43406411-43406461 | HPAEpiC | pulmonary alveolar: | n/a |
5 | chr8:43401874-43401924 | AG10803 | skin: | n/a |
6 | chr8:43129374-43129424 | HIPEpiC | eye: | n/a |
7 | chr8:43404458-43404508 | MCF10A-Er-Src | breast: | n/a |
8 | chr8:43401874-43401924 | NHDF-neo | bronchial: | n/a |
9 | chr8:43131535-43131585 | U87 | brain: | n/a |
10 | chr8:43406411-43406461 | HPAEpiC | pulmonary alveolar: | n/a |
11 | chr8:43401874-43401924 | AG10803 | skin: | n/a |
12 | chr8:43129374-43129424 | HIPEpiC | eye: | n/a |
13 | chr8:43402930-43402980 | SK-N-MC | brain: | n/a |
14 | chr8:43131260-43131310 | HCF | heart: | n/a |
15 | chr8:43129374-43129424 | PANC-1 | pancreas: | n/a |
16 | chr8:43147602-43147652 | A549 | lung: | n/a |
17 | chr8:43136162-43136212 | ProgFib | skin: | n/a |
18 | chr8:43417291-43417341 | LNCaP | prostate: | n/a |
19 | chr8:43406144-43406194 | HPAEpiC | pulmonary alveolar: | n/a |
20 | chr8:43405687-43405737 | HCT-116 | colon: | n/a |
21 | chr8:43404458-43404508 | U87 | brain: | n/a |
22 | chr8:43136162-43136212 | CMK | blood: | n/a |
23 | chr8:43406314-43406364 | A549 | lung: | n/a |
24 | chr8:43406411-43406461 | NH-A | brain: | n/a |
25 | chr8:43406314-43406364 | HUVEC | blood vessel: | n/a |
26 | chr8:43132125-43132175 | NH-A | brain: | n/a |
27 | chr8:43129374-43129424 | SK-N-SH | brain: | n/a |
28 | chr8:43127238-43127288 | H1-hESC | embryonic stem cell: | embryo |
29 | chr8:43136162-43136212 | HCF | heart: | n/a |
30 | chr8:43403277-43403327 | PrEC | prostate: | n/a |
31 | chr8:43127072-43127122 | Jurkat | blood: | n/a |
32 | chr8:43131656-43131706 | SKMC | muscle: | n/a |
33 | chr8:43157775-43157825 | K562 | blood: | n/a |
34 | chr8:43147564-43147614 | HCF | heart: | n/a |
35 | chr8:43213875-43213925 | BE2_C | brain: | n/a |
36 | chr8:43157775-43157825 | AG10803 | skin: | n/a |
37 | chr8:43136162-43136212 | HCPEpiC | choroid plexus: | n/a |
38 | chr8:43146894-43146944 | ECC-1 | luminal epithelium: | n/a |
39 | chr8:43418406-43418456 | U87 | brain: | n/a |
40 | chr8:43278783-43278833 | NH-A | brain: | n/a |
41 | chr8:43146388-43146438 | NH-A | brain: | n/a |
42 | chr8:43405687-43405737 | ovcar-3 | ovarian: | n/a |
43 | chr8:43405739-43405789 | NH-A | brain: | n/a |
44 | chr8:43131353-43131403 | Caco-2 | colon: | n/a |
45 | chr8:43147211-43147261 | HCPEpiC | choroid plexus: | n/a |
46 | chr8:43131535-43131585 | ProgFib | skin: | n/a |
47 | chr8:43147564-43147614 | BJ | skin: | n/a |
48 | chr8:43213875-43213925 | GM19239 | blood: | n/a |
49 | chr8:43136445-43136495 | K562 | blood: | n/a |
50 | chr8:43132256-43132306 | Caco-2 | colon: | n/a |
(count:13 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:42947579..42949100-chr8:43300446..43303387,2 | MCF-7 | breast: | |
2 | chr8:42948115..42950146-chr8:43255758..43258426,2 | K562 | blood: | |
3 | chr8:43370024..43372377-chr8:43374871..43376951,2 | K562 | blood: | |
4 | chr8:43370024..43372377-chr8:43374871..43376951,2 | K562 | blood: | |
5 | chr8:43143648..43145525-chr8:43156290..43158603,2 | MCF-7 | breast: | |
6 | chr8:42947110..42950521-chr8:43131245..43133918,5 | K562 | blood: | |
7 | chr8:42948083..42948640-chr8:43285913..43286769,2 | MCF-7 | breast: | |
8 | chr8:43395245..43397661-chr8:43402500..43405220,3 | K562 | blood: | |
9 | chr5:82184309..82184963-chr8:43234719..43235395,2 | MCF-7 | breast: | |
10 | chr15:63385860..63386443-chr8:43553599..43554374,2 | MCF-7 | breast: | |
11 | chr8:42947421..42949412-chr8:43129646..43132331,3 | K562 | blood: | |
12 | chr8:43394978..43396738-chr8:43399115..43401110,2 | K562 | blood: | |
13 | chr8:42948202..42949138-chr8:43130975..43131934,4 | K562 | blood: |
(count:14 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-HGSNAT-7 | chr8:43307943-43308055 | NONHSAT126356 |
2 | lnc-HGSNAT-7 | chr8:43306599-43306780 | NONHSAT126356 |
3 | lnc-HGSNAT-10 | chr8:43394280-43394615 | NONHSAT126362 |
4 | lnc-RNF170-9 | chr8:43529413-43529734 | NONHSAT126368 |
5 | lnc-HGSNAT-12 | chr8:43527966-43528218 | NONHSAT126367 |
6 | lnc-HGSNAT-6 | chr8:43236787-43237091 | NONHSAT126355 |
7 | lnc-HGSNAT-5 | chr8:43233441-43233652 | NONHSAT126354 |
8 | lnc-HGSNAT-8 | chr8:43349080-43349905 | NONHSAT126357 |
9 | lnc-HGSNAT-7 | chr8:43298045-43298224 | NONHSAT126356 |
10 | lnc-HGSNAT-7 | chr8:43299491-43299558 | NONHSAT126356 |
11 | lnc-HGSNAT-4 | chr8:43169091-43169343 | NONHSAT126351 |
12 | lnc-HGSNAT-9 | chr8:43368786-43369564 | NONHSAT126361 |
13 | lnc-RNF170-8 | chr8:43366963-43367176 | NONHSAT126358 |
14 | lnc-HGSNAT-7 | chr8:43303948-43304047 | NONHSAT126356 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253195 | TF binding region |
ENSG00000254145 | TF binding region |
ENSG00000250637 | TF binding region |
ENSG00000201329 | TF binding region |
AFG3L2P1 | TF binding region |
ENSG00000254342 | TF binding region |
RN7SKP41 | TF binding region |
ENSG00000253486 | TF binding region |
ENSG00000253707 | TF binding region |
ENSG00000264094 | TF binding region |
ENSG00000234713 | TF binding region |
CYP4F44P | TF binding region |
ENSG00000221295 | TF binding region |
ENSG00000253845 | TF binding region |
ENSG00000255497 | TF binding region |
ENSG00000253198 | TF binding region |
POTEA | TF binding region |
ENSG00000253319 | TF binding region |
RNU6-104P | TF binding region |
SNX18P27 | TF binding region |
ENSG00000254069 | TF binding region |
ENSG00000253195 | CpG island |
ENSG00000254145 | CpG island |
ENSG00000250637 | CpG island |
ENSG00000201329 | CpG island |
AFG3L2P1 | CpG island |
ENSG00000254342 | CpG island |
RN7SKP41 | CpG island |
ENSG00000253486 | CpG island |
ENSG00000253707 | CpG island |
ENSG00000264094 | CpG island |
ENSG00000234713 | CpG island |
CYP4F44P | CpG island |
ENSG00000221295 | CpG island |
ENSG00000253845 | CpG island |
ENSG00000255497 | CpG island |
ENSG00000253198 | CpG island |
POTEA | CpG island |
ENSG00000253319 | CpG island |
RNU6-104P | CpG island |
SNX18P27 | CpG island |
ENSG00000254069 | CpG island |
ENSG00000185900 | chromatin interactions |
ENSG00000253748 | chromatin interactions |
ENSG00000238509 | chromatin interactions |
ENSG00000253195 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570782601 | chr8:43127130-43127131 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs544934022 | chr8:43127145-43127146 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs116677851 | chr8:43127187-43127188 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs188002564 | chr8:43127190-43127191 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs62516805 | chr8:43127200-43127201 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs560199171 | chr8:43127218-43127219 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs529373787 | chr8:43127238-43127239 | Inactive region | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs549085280 | chr8:43127239-43127240 | Inactive region | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs144256728 | chr8:43127240-43127241 | Inactive region | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs531737410 | chr8:43127246-43127247 | Inactive region | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs531604620 | chr8:43128051-43128052 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs151320435 | chr8:43128493-43128494 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs545405830 | chr8:43128588-43128589 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs567820906 | chr8:43128611-43128612 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs536842146 | chr8:43128634-43128635 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs549610644 | chr8:43128699-43128700 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs545789259 | chr8:43128784-43128785 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs538243234 | chr8:43128801-43128802 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs527696771 | chr8:43129215-43129216 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs112760346 | chr8:43129230-43129231 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs141352595 | chr8:43129270-43129271 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs377763300 | chr8:43129308-43129309 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs561617996 | chr8:43129312-43129313 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs530309754 | chr8:43129353-43129354 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs550386309 | chr8:43129374-43129375 | Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs564086889 | chr8:43129404-43129405 | Inactive region | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs6987171 | chr8:43129405-43129406 | Inactive region | TF binding regionCpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs541011578 | chr8:43129413-43129414 | Inactive region | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs565294497 | chr8:43129428-43129429 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs373262035 | chr8:43129445-43129446 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs7012007 | chr8:43129447-43129448 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs7012014 | chr8:43129466-43129467 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs574432713 | chr8:43129486-43129487 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs536828572 | chr8:43129490-43129491 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs145034281 | chr8:43129501-43129502 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs7008122 | chr8:43129576-43129577 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs184136944 | chr8:43129607-43129608 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs6987505 | chr8:43129647-43129648 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs572468332 | chr8:43129669-43129670 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs6988652 | chr8:43129677-43129678 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs6992507 | chr8:43129700-43129701 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs530453816 | chr8:43129701-43129702 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs543784027 | chr8:43129720-43129721 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs563869486 | chr8:43129755-43129756 | Inactive region | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs532605406 | chr8:43129804-43129805 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs138882316 | chr8:43129806-43129807 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs565481857 | chr8:43129828-43129829 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs528066533 | chr8:43129829-43129830 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs532806837 | chr8:43129880-43129881 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs114586916 | chr8:43129903-43129904 | Inactive region | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Seminomas | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Bladder cancer | 19088036 | CNVD |
Breast cancer | 17001308 | CNVD |
Breast cancer | 17157792 | CNVD |
Cancer | 17001308 | CNVD |
Cancer | 18840272 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Chordoma | 18071362 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21785460 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Breast cancer | 21045282 | CNVD |
Lung cancer | 17925434 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Mental retardation | 17124404 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Schizophrenia | 20967226 | CNVD |
Bipolar disorder | 19214233 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:43129200-43129400 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr8:43130600-43130800 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
3 | chr8:43130600-43132600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr8:43130800-43131000 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
5 | chr8:43130800-43131200 | Bivalent/Poised TSS | HepG2 | liver |
6 | chr8:43130800-43131200 | Enhancers | K562 | blood |
7 | chr8:43130800-43131400 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
8 | chr8:43131000-43131200 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
9 | chr8:43131000-43131400 | Enhancers | GM12878-XiMat | blood |
10 | chr8:43131000-43131800 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr8:43131000-43131800 | Bivalent Enhancer | Placenta | Placenta |
12 | chr8:43131000-43132200 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr8:43131400-43131600 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
14 | chr8:43131600-43131800 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
15 | chr8:43131600-43132200 | Active TSS | GM12878-XiMat | blood |
16 | chr8:43131800-43132400 | Flanking Bivalent TSS/Enh | Placenta | Placenta |
17 | chr8:43131800-43132600 | Flanking Bivalent TSS/Enh | Foreskin Melanocyte Primary Cells skin03 | Skin |
18 | chr8:43132000-43132200 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
19 | chr8:43132000-43132200 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
20 | chr8:43132000-43132200 | Flanking Bivalent TSS/Enh | Foreskin Melanocyte Primary Cells skin01 | Skin |
21 | chr8:43132000-43132200 | Enhancers | Fetal Heart | heart |
22 | chr8:43132000-43132200 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
23 | chr8:43132000-43132200 | Bivalent Enhancer | Thymus | Thymus |
24 | chr8:43132000-43132200 | Flanking Bivalent TSS/Enh | Spleen | Spleen |
25 | chr8:43132000-43132200 | Bivalent Enhancer | Monocytes-CD14+_RO01746 | blood |
26 | chr8:43132000-43132400 | Bivalent Enhancer | Lung | lung |
27 | chr8:43132000-43132600 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
28 | chr8:43132000-43132600 | Bivalent/Poised TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
29 | chr8:43132000-43134000 | Weak transcription | Right Atrium | heart |
30 | chr8:43132200-43132400 | Flanking Bivalent TSS/Enh | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
31 | chr8:43132200-43132400 | Bivalent/Poised TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
32 | chr8:43132200-43132400 | Bivalent Enhancer | Spleen | Spleen |
33 | chr8:43132200-43132600 | Bivalent/Poised TSS | IMR90 fetal lung fibroblasts Cell Line | lung |
34 | chr8:43132200-43132600 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
35 | chr8:43132600-43133000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
36 | chr8:43134000-43134200 | Active TSS | Right Atrium | heart |
37 | chr8:43135600-43136200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
38 | chr8:43136000-43136200 | Bivalent Enhancer | Primary T helper cells PMA-I stimulated | -- |
39 | chr8:43136000-43136400 | Bivalent Enhancer | Primary B cells from peripheral blood | blood |
40 | chr8:43136000-43136400 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
41 | chr8:43136000-43136400 | Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
42 | chr8:43136000-43136400 | Bivalent Enhancer | Brain Anterior Caudate | brain |
43 | chr8:43136000-43136800 | Bivalent Enhancer | HepG2 | liver |
44 | chr8:43136200-43136400 | Flanking Bivalent TSS/Enh | HUES6 Cell Line | embryonic stem cell |
45 | chr8:43136200-43136400 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
46 | chr8:43136200-43136400 | Bivalent Enhancer | Primary hematopoietic stem cells | blood |
47 | chr8:43136200-43136400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
48 | chr8:43136200-43136400 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
49 | chr8:43136200-43136400 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin03 | Skin |
50 | chr8:43136200-43136400 | Bivalent Enhancer | Liver | Liver |